Morgan Stanley downgraded Core Labs from Equal-Weight to Underweight and set a new price target of $20.00
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/12/2025 | $15.00 → $16.00 | Sell → Neutral | Citigroup |
| 6/30/2023 | $22.00 → $21.00 | Neutral → Sell | Citigroup |
| 4/18/2023 | $21.50 | Neutral → Underperform | BofA Securities |
| 1/9/2023 | Underperform → Neutral | BofA Securities | |
| 10/7/2022 | $24.00 → $17.00 | Sell → Neutral | Citigroup |
| 9/26/2022 | $20.00 | Equal-Weight → Underweight | Morgan Stanley |
| 4/18/2022 | $19.50 → $21.30 | Neutral → Underweight | Piper Sandler |
| 1/18/2022 | $32.00 → $30.00 | Equal-Weight | Morgan Stanley |
Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously
Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously
BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50
11-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)
SCHEDULE 13G/A - Core Laboratories Inc. /DE/ (0001958086) (Subject)
SD - Core Laboratories Inc. /DE/ (0001958086) (Filer)
HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EDT on July 30, 2026. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on July 29, 2026, and may be accessed through the Company's website at www.corelab.com/investors.To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast
NEW YORK, June 26, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Gulfport Energy Corp. (NYSE:GPOR) will replace Select Medical Holdings Corp. (NYSE:SEM) effective prior to the opening of trading on Wednesday, July 1. Select Medical Holdings is being acquired in a deal expected to be completed soon, pending final closing conditions.Mobility Global Inc. (NYSE:MBGL) will replace Core Laboratories Inc. (NYSE:CLB) effective prior to the opening of trading on Thursday, July 2. S&P 500 constituent S&P Global Inc. (NYSE:SPGI) is spinning off Mobility Global in a transaction expected to be completed July 1. Core Laboratories is no longer represen
REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEARGAAP LOSS PER SHARE OF $0.02; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEARFREE CASH FLOW OF $0.5 MILLIONNET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICECOMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDENDHOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,0
HOUSTON, June 30, 2026 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its second quarter 2026 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EDT on July 30, 2026. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on July 29, 2026, and may be accessed through the Company's website at www.corelab.com/investors.To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast
REVENUE OF $121.8 MILLION, DOWN 12% SEQUENTIALLY AND FLAT YEAR-OVER-YEAROPERATING INCOME OF $1.9 MILLION; EX-ITEMS, $6.6 MILLION, DOWN 58% SEQUENTIALLY AND 44% YEAR-OVER-YEARGAAP LOSS PER SHARE OF $0.02; EPS EX-ITEMS OF $0.06, DOWN 72% SEQUENTIALLY AND 58% YEAR-OVER-YEARFREE CASH FLOW OF $0.5 MILLIONNET DEBT INCREASED BY $3.9 MILLION; LEVERAGE RATIO AT 1.20COMPANY REPURCHASED 51,781 SHARES OF COMMON STOCK, FOR $0.9 MILLION AGGREGATE PURCHASE PRICECOMPANY ANNOUNCES Q2 2026 QUARTERLY DIVIDENDHOUSTON, April 29, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") reported first quarter 2026 revenue of $121,800,000. Core's operating income was $1,900,0
FIRST QUARTER 2026 EARNINGS WEBCAST AT 7:30 A.M. CDT / 8:30 A.M. EDT ON APRIL 30, 2026HOUSTON, March 23, 2026 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core," "Core Lab," or the "Company") continues to evaluate and monitor the evolving geopolitical conflict in the Middle East and its effect on the Company's first quarter 2026 financial results. Core Lab is working with clients and its local teams to manage operations and mitigate impacts on project execution through a rapidly changing operating environment. The safety and security of the Company's employees remain its highest priority.At this time, due to regional instability, including client-driven project delays, travel const
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)
NEW YORK, June 26, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600: Gulfport Energy Corp. (NYSE:GPOR) will replace Select Medical Holdings Corp. (NYSE:SEM) effective prior to the opening of trading on Wednesday, July 1. Select Medical Holdings is being acquired in a deal expected to be completed soon, pending final closing conditions.Mobility Global Inc. (NYSE:MBGL) will replace Core Laboratories Inc. (NYSE:CLB) effective prior to the opening of trading on Thursday, July 2. S&P 500 constituent S&P Global Inc. (NYSE:SPGI) is spinning off Mobility Global in a transaction expected to be completed July 1. Core Laboratories is no longer represen
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)
SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)